Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Biotech
Medera plans SPAC merger to advance cardiac gene therapies
The SPAC is bringing around $149.5 million to the party, which will contribute to the combined company’s implied initial value of $622.6 million.
James Waldron
Sep 5, 2024 10:50am
Pfizer and Flagship add Quotient to multibillion-dollar equation
Aug 28, 2024 6:30am
Despite cash infusion, Windtree still needs rescue within a year
Aug 21, 2024 5:45am
Arrowhead dips toes into obesity pond with 2 preclinical assets
Aug 14, 2024 3:50pm
Cardio-focused Cardurion raises hearty $260M series B
Jul 16, 2024 3:47pm
Marea ropes in $190M for clinical-stage cardiometabolic program
Jun 18, 2024 7:00am